REFERENCES
- Rosenfeld ME. Inflammation, lipids, and free radicals: lessons learned from the atherogenic process. Semin Reprod Endocrinol 1998; 16: 249–261.
- Steinbrecher UP. Receptors for oxidized low density lipoprotein. Biochim Biophys Acta 1999; 1436: 279–298.
- Weber C, Draude G, Weber KSC, Wubert J, Lorenz RL, Weber PC. Downregulation by tumor necrosis factor-alpha of monocyte CCR2 expression and monocyte chemotactic protein-l-induced transendothelial migration is antagonized by oxidized low-density lipoprotein — a potential mechanism of monocyte retention in atherosclerotic lesions. Atherosclerosis 1999; 145: 115–123.
- Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745–2756.
- Navazo MD, Daviet L, Ninio E, McGregor JL. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol 1996; 16: 1033–1039.